Medical Therapy for Stent Discomfort

2.

Joshi HB, et al. Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol. 2003;169(3):1065–9. discussion 1069.PubMedCrossRef

3.

Hao P, et al. Clinical evaluation of double-pigtail stent in patients with upper urinary tract diseases: report of 2685 cases. J Endourol. 2008;22(1):65–70.PubMedCrossRef

4.

Borboroglu PG, et al. Ureteral stenting after ureteroscopy for distal ureteral calculi: a multi-institutional prospective randomized controlled study assessing pain, outcomes and complications. J Urol. 2001;166(5):1651–7.PubMedCrossRef

5.

Thomas R. Indwelling ureteral stents: impact of material and shape on patient comfort. J Endourol. 1993;7(2):137–40.PubMedCrossRef

6.

Rane A, et al. Have stent-related symptoms anything to do with placement technique? J Endourol. 2001;15(7):741–5.PubMedCrossRef

7.

Miyaoka R, Monga M. Ureteral stent discomfort: Etiology and management. Indian J Urol. 2009;25(4):455–60.PubMedCrossRef

8.

Chew BH, et al. Pilot study of ureteral movement in stented patients: first step in understanding dynamic ureteral anatomy to improve stent comfort. J Endourol. 2007;21(9):1069–75.PubMedCrossRef

9.

Mosli HA, et al. Vesicoureteral reflux in patients with double pigtail stents. J Urol. 1991;146(4):966–9.PubMed

10.

Yossepowitch O, et al. Assessment of vesicoureteral reflux in patients with self-retaining ureteral stents: implications for upper urinary tract instillation. J Urol. 2005;173(3):890–3.PubMedCrossRef

11.

El-Nahas AR, et al. Self-retaining ureteral stents: analysis of factors responsible for patients’ discomfort. J Endourol. 2006;20(1):33–7.PubMedCrossRef

12.

Weiss RM. Uretral function. Urology. 1978;12(2):114–33.PubMedCrossRef

13.

Dixon JS, Gosling JA. The fine structure of pacemaker cells in the pig renal calices. Anat Rec. 1973;175(2):139–53.PubMedCrossRef

14.

Malin Jr JM, Deane RF, Boyarsky S. Characterisation of adrenergic receptors in human ureter. Br J Urol. 1970;42(2):171–4.PubMedCrossRef

15.

Mastrangelo D, Iselin CE. Urothelium dependent inhibition of rat ureter contractile activity. J Urol. 2007;178(2):702–9.PubMedCrossRef

16.

Lipkin M, Shah O. The use of alpha-blockers for the treatment of nephrolithiasis. Rev Urol. 2006;8 Suppl 4:S35–42.PubMed

17.

Sigala S, et al. Evidence for the presence of alpha1 adrenoceptor subtypes in the human ureter. Neurourol Urodyn. 2005;24(2):142–8.PubMedCrossRef

18.

Weiss RM, Bassett AL, Hoffman BF. Adrenergic innervation of the ureter. Invest Urol. 1978;16(2):123–7.PubMed

19.

Joshi HB, et al. Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol. 2003;169(3):1060–4.PubMedCrossRef

20.

Damiano R, et al. Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study. J Endourol. 2008;22(4):651–6.PubMedCrossRef

21.

Wang CJ, Huang SW, Chang CH. Effects of specific alpha-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study. Urol Res. 2009;37(3):147–52.PubMedCrossRef

22.

Deliveliotis C, et al. Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology. 2006;67(1):35–9.PubMedCrossRef

23.

Beddingfield R, et al. Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study. J Urol. 2009;181(1):170–6.PubMedCrossRef

24.

Lingeman JE, et al. Assessing the impact of ureteral stent design on patient comfort. J Urol. 2009;181(6):2581–7.PubMedCrossRef

Only gold members can continue reading. Log In or Register to continue